Harpoon Therapeutics Inc – Filings and Transcripts – BamSEC

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

ended 09/30/22 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Ownership Filter

Glazer Capital, LLC

Gamco Investors, Inc. Et Al

Merck Sharp & Dohme LLC

Lathi Vijay K, New Leaf Ventures III, L.P., New Leaf Venture Associates III, L.P., New Leaf Venture Management III, L.L.C., New Leaf Biopharma Opportunities II, L.P., New Leaf BPO Management II, L.L.C, New Leaf BPO Associates II, L.P.

Silvernail Lauren P

News Filter

Termination of Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Shareholder Vote Results

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Preliminary proxy related to merger

Proxy materials by non-management

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC